Cita APA

Guerrero-Zotano, Á., Belli, S., Zielinski, C., Gil Gil, M. J., Fernández-Serra, A., Ruiz‑Borrego, M., . . . Martín, M. (2023). CCNE1 and PLK1 Mediate Resistance to Palbociclib in HR+/HER2- Metastatic Breast Cancer.

Citación estilo Chicago

Guerrero-Zotano, Ángel, et al. CCNE1 and PLK1 Mediate Resistance to Palbociclib in HR+/HER2- Metastatic Breast Cancer. 2023.

Cita MLA

Guerrero-Zotano, Ángel, et al. CCNE1 and PLK1 Mediate Resistance to Palbociclib in HR+/HER2- Metastatic Breast Cancer. 2023.